Bayer Appeal, EU Patents, AbbVie: Intellectual Property

Bayer AG’s patent on the birth control pill Yaz is invalid, a U.S. appeals court said in a decision ensuring that Actavis Inc. and Novartis AG’s Sandoz unit can sell copies of the contraceptive.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.